Outcome following the surgical management of varicocele in children and adolescents: a systematic review and meta-analysis.

IF 2.6 4区 医学 Q2 UROLOGY & NEPHROLOGY
Therapeutic Advances in Urology Pub Date : 2023-10-20 eCollection Date: 2023-01-01 DOI:10.1177/17562872231206239
Sarthak Tandon, Daniel Bennett, Ramesh Mark Nataraja, Maurizio Pacilli
{"title":"Outcome following the surgical management of varicocele in children and adolescents: a systematic review and meta-analysis.","authors":"Sarthak Tandon,&nbsp;Daniel Bennett,&nbsp;Ramesh Mark Nataraja,&nbsp;Maurizio Pacilli","doi":"10.1177/17562872231206239","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The ideal surgical approach for the management of varicocele in children and adolescents remains controversial. Several techniques are available including artery- or lymphatic-sparing with optical magnification (<i>via</i> open inguinal or sub-inguinal approach), laparoscopic, antegrade and retrograde embolization/sclerotherapy.</p><p><strong>Objectives: </strong>We aimed to appraise the clinical outcomes of these techniques in children and adolescents.</p><p><strong>Data sources and methods: </strong>A systematic review was conducted (1997-2023). Meta-analysis or proportional meta-analysis for non-comparative studies (Freeman-Tukey transformation) using the random effects model was conducted. Results are expressed as overall proportion % and 95% confidence interval (CI).</p><p><strong>Results: </strong>We identified 1910 studies; 632 duplicates were removed, 1278 were screened, 203 were reviewed and 56 were included, with 12 reporting on 2 different techniques (total of 68 data sets). Optical magnification <i>via</i> inguinal approach (498 cases): recurrence 2.5% (0.6-5.6), hydrocele 1.6% (0.47-3.4), testicular atrophy 1% (0.3-2.0), complications 1.1% (0.2-2.6); optical magnification <i>via</i> sub-inguinal approach (592 cases): recurrence 2.1% (0.7-4.4), hydrocele 1.26% (0.5-2.3), testicular atrophy 0.5% (0.1-1.3), complications 4% (1.0-8.8). Laparoscopic with mass-ligation/division (1943 cases): recurrence 2.9% (1.5-4.6), hydrocele 11.4% (8.3-14.9); complications 1.5% (0.6-2.9); laparoscopic with lymphatic-sparing (974 cases): recurrence 2.4% (1.5-3.5), hydrocele 1.2% (0.45-3.36), complications 1.2% (0.05-3.9); laparoscopic with artery-sparing (228 cases): recurrence 6.6% (2.3-12.9), hydrocele 6.5% (2.6-12.0). Antegrade embolization/sclerotherapy (403 cases): recurrence 7.6% (5.2-10.4), hydrocele 0.8% (0.17-1.9), technical failure 0.6% (0.1-1.6), complications 4.0% (2.3-6.1); retrograde embolization/sclerotherapy (509 cases): recurrence 6.9% (4.6-9.5), hydrocele 0.8% (0.05-2.5), technical failure 10.2% (4.6-17.6), and complications 4.8% (1.0-11.2).</p><p><strong>Conclusion: </strong>The recurrence rate varies between 2.1% and 7.6% and is higher with the embolization/sclerotherapy techniques. Post-operative hydrocele rate varies between 0.8% and 11.4% and is higher with the laparoscopic mass-ligation/division technique. Testicular atrophy has not been reported with the laparoscopic and embolization/sclerotherapy techniques. The retrograde embolization technique is associated with 10% technical failure (inability to complete the procedure). The laparoscopic lymphatic-sparing technique is characterized by the lowest recurrence rate, incidence of hydrocele and other complications, and no reports of testicular atrophy.</p>","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":null,"pages":null},"PeriodicalIF":2.6000,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/09/7e/10.1177_17562872231206239.PMC10590051.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17562872231206239","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The ideal surgical approach for the management of varicocele in children and adolescents remains controversial. Several techniques are available including artery- or lymphatic-sparing with optical magnification (via open inguinal or sub-inguinal approach), laparoscopic, antegrade and retrograde embolization/sclerotherapy.

Objectives: We aimed to appraise the clinical outcomes of these techniques in children and adolescents.

Data sources and methods: A systematic review was conducted (1997-2023). Meta-analysis or proportional meta-analysis for non-comparative studies (Freeman-Tukey transformation) using the random effects model was conducted. Results are expressed as overall proportion % and 95% confidence interval (CI).

Results: We identified 1910 studies; 632 duplicates were removed, 1278 were screened, 203 were reviewed and 56 were included, with 12 reporting on 2 different techniques (total of 68 data sets). Optical magnification via inguinal approach (498 cases): recurrence 2.5% (0.6-5.6), hydrocele 1.6% (0.47-3.4), testicular atrophy 1% (0.3-2.0), complications 1.1% (0.2-2.6); optical magnification via sub-inguinal approach (592 cases): recurrence 2.1% (0.7-4.4), hydrocele 1.26% (0.5-2.3), testicular atrophy 0.5% (0.1-1.3), complications 4% (1.0-8.8). Laparoscopic with mass-ligation/division (1943 cases): recurrence 2.9% (1.5-4.6), hydrocele 11.4% (8.3-14.9); complications 1.5% (0.6-2.9); laparoscopic with lymphatic-sparing (974 cases): recurrence 2.4% (1.5-3.5), hydrocele 1.2% (0.45-3.36), complications 1.2% (0.05-3.9); laparoscopic with artery-sparing (228 cases): recurrence 6.6% (2.3-12.9), hydrocele 6.5% (2.6-12.0). Antegrade embolization/sclerotherapy (403 cases): recurrence 7.6% (5.2-10.4), hydrocele 0.8% (0.17-1.9), technical failure 0.6% (0.1-1.6), complications 4.0% (2.3-6.1); retrograde embolization/sclerotherapy (509 cases): recurrence 6.9% (4.6-9.5), hydrocele 0.8% (0.05-2.5), technical failure 10.2% (4.6-17.6), and complications 4.8% (1.0-11.2).

Conclusion: The recurrence rate varies between 2.1% and 7.6% and is higher with the embolization/sclerotherapy techniques. Post-operative hydrocele rate varies between 0.8% and 11.4% and is higher with the laparoscopic mass-ligation/division technique. Testicular atrophy has not been reported with the laparoscopic and embolization/sclerotherapy techniques. The retrograde embolization technique is associated with 10% technical failure (inability to complete the procedure). The laparoscopic lymphatic-sparing technique is characterized by the lowest recurrence rate, incidence of hydrocele and other complications, and no reports of testicular atrophy.

Abstract Image

Abstract Image

Abstract Image

儿童和青少年精索静脉曲张手术治疗后的结果:一项系统综述和荟萃分析。
背景:治疗儿童和青少年精索静脉曲张的理想手术方法仍然存在争议。有几种技术可用,包括光学放大保留动脉或淋巴管(通过腹股沟开放或腹股沟下入路)、腹腔镜、顺行和逆行栓塞/硬化治疗。目的:我们旨在评估这些技术在儿童和青少年中的临床效果。数据来源和方法:进行了系统回顾(1997-2023)。使用随机效应模型对非比较研究(Freeman-Tukey变换)进行荟萃分析或比例荟萃分析。结果用总体比例%和95%置信区间(CI)表示。结果:我们确定了1910项研究;去除632个重复项,筛选1278个,审查203个,纳入56个,其中12个报告了2种不同的技术(共68个数据集)。经腹股沟入路光学放大(498例):复发2.5%(0.6-5.6),鞘膜积液1.6%(0.47-3.4),睾丸萎缩1%(0.3-2.0),并发症1.1%(0.2-2.6);经腹股沟下入路光学放大术592例:复发2.1%(0.7-4.4),积液1.26%(0.5-2.3),睾丸萎缩0.5%(0.1-1.3),并发症4%(1.0-8.8);并发症1.5%(0.6-2.9);腹腔镜保留淋巴结974例:复发2.4%(1.5-3.5),鞘膜积液1.2%(0.45-3.36),并发症1.2%(0.05-3.9);腹腔镜保留动脉(228例):复发6.6%(2.3-12.9),积液6.5%(2.6-12.0)。顺行栓塞/硬化治疗(403例):术后复发7.6%(5.2-10.4),积液0.8%(0.17-1.9),技术失败0.6%(0.1-1.6),并发症4.0%(2.3-6.1);逆行栓塞/硬化治疗509例:复发6.9%(4.6-9.5),鞘膜积液0.8%(0.05-2.5),技术失败10.2%(4.6-17.6),并发症4.8%(1.0-11.2)。术后鞘膜积液发生率在0.8%至11.4%之间,腹腔镜大面积结扎/切开术的发生率更高。腹腔镜和栓塞/硬化治疗技术尚未报道睾丸萎缩。逆行栓塞技术有10%的技术失败(无法完成手术)。腹腔镜保留淋巴管技术的特点是复发率最低,鞘膜积液和其他并发症的发生率最低,没有睾丸萎缩的报告。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.70
自引率
0.00%
发文量
39
审稿时长
10 weeks
期刊介绍: Therapeutic Advances in Urology delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of urology. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in urology, providing a forum in print and online for publishing the highest quality articles in this area. The editors welcome articles of current interest across all areas of urology, including treatment of urological disorders, with a focus on emerging pharmacological therapies.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信